Ilaria Attili

23PUBLICATIONS
52CO-AUTHORS
Molecular targetsCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersOncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Jan 20, 2026
Actionable driver gene alterations in early-stage non-small cell lung cancer: a review.

Ilaria Attili, Pasquale Pisapia, Gianluca Spitaleri

|Jul 29, 2025
Management of MET-Driven Resistance to Osimertinib in EGFR-Mutant Non-Small Cell Lung Cancer.

Panagiotis Agisilaos Angelopoulos, Antonio Passaro, Ilaria Attili

|Jul 29, 2025
Co-Occurring Genomic Alterations in NSCLC: Making Order into a Crowded List.

Ilaria Attili, Federico Pio Fabrizio, Filippo de Marinis

|Jun 27, 2025
HER2 in Non-Small Cell Lung Cancer (NSCLC): Evolution of the Therapeutic Landscape and Emerging Drugs-A Long Way to the Top.

Pamela Trillo Aliaga, Gianluca Spitaleri, Ilaria Attili

|Feb 25, 2025
Perioperative Chemo-Immunotherapy in Non-Oncogene-Addicted Resectable Non-Small Cell Lung Cancer (NSCLC): Italian Expert Panel Meeting.

Filippo de Marinis, Andrea Ardizzoni, Ilaria Attili

|Jan 21, 2025
MAPK Pathway-Activating Alteration and Immunotherapy Efficacy in Squamous Cell Lung Carcinoma: Results from the Randomized, Prospective SQUINT Trial.

Federico Cappuzzo, Biagio Ricciuti, Angelo Delmonte

Pageof 4